nodes	percent_of_prediction	percent_of_DWPC	metapath
Nelarabine—Motor dysfunction—Riluzole—amyotrophic lateral sclerosis	0.0897	0.119	CcSEcCtD
Nelarabine—Pneumothorax—Riluzole—amyotrophic lateral sclerosis	0.0261	0.0348	CcSEcCtD
Nelarabine—Adenosine triphosphate—ASNA1—amyotrophic lateral sclerosis	0.0241	1	CrCbGaD
Nelarabine—Cerebral haemorrhage—Riluzole—amyotrophic lateral sclerosis	0.0235	0.0313	CcSEcCtD
Nelarabine—Polyp—Riluzole—amyotrophic lateral sclerosis	0.0214	0.0285	CcSEcCtD
Nelarabine—Cyst—Riluzole—amyotrophic lateral sclerosis	0.0195	0.0259	CcSEcCtD
Nelarabine—Blood creatine phosphokinase increased—Riluzole—amyotrophic lateral sclerosis	0.0189	0.0252	CcSEcCtD
Nelarabine—Neuritis—Riluzole—amyotrophic lateral sclerosis	0.0174	0.0232	CcSEcCtD
Nelarabine—Pleural effusion—Riluzole—amyotrophic lateral sclerosis	0.017	0.0226	CcSEcCtD
Nelarabine—Petechiae—Riluzole—amyotrophic lateral sclerosis	0.0158	0.021	CcSEcCtD
Nelarabine—DGUOK—medulla oblongata—amyotrophic lateral sclerosis	0.0149	0.111	CbGeAlD
Nelarabine—Blood bilirubin increased—Riluzole—amyotrophic lateral sclerosis	0.0138	0.0183	CcSEcCtD
Nelarabine—Dysarthria—Riluzole—amyotrophic lateral sclerosis	0.0138	0.0183	CcSEcCtD
Nelarabine—DGUOK—Nucleotide metabolism—GSR—amyotrophic lateral sclerosis	0.0134	0.147	CbGpPWpGaD
Nelarabine—Gait disturbance—Riluzole—amyotrophic lateral sclerosis	0.0133	0.0177	CcSEcCtD
Nelarabine—DGUOK—spinal cord—amyotrophic lateral sclerosis	0.0133	0.0994	CbGeAlD
Nelarabine—Coordination abnormal—Riluzole—amyotrophic lateral sclerosis	0.0132	0.0176	CcSEcCtD
Nelarabine—Depressed level of consciousness—Riluzole—amyotrophic lateral sclerosis	0.0126	0.0167	CcSEcCtD
Nelarabine—Coma—Riluzole—amyotrophic lateral sclerosis	0.0119	0.0158	CcSEcCtD
Nelarabine—Neoplasm—Riluzole—amyotrophic lateral sclerosis	0.0118	0.0157	CcSEcCtD
Nelarabine—Hypertonia—Riluzole—amyotrophic lateral sclerosis	0.0114	0.0152	CcSEcCtD
Nelarabine—Mental disability—Riluzole—amyotrophic lateral sclerosis	0.0113	0.015	CcSEcCtD
Nelarabine—Sepsis—Riluzole—amyotrophic lateral sclerosis	0.0113	0.015	CcSEcCtD
Nelarabine—DGUOK—nervous system—amyotrophic lateral sclerosis	0.0112	0.0837	CbGeAlD
Nelarabine—DGUOK—central nervous system—amyotrophic lateral sclerosis	0.0108	0.0806	CbGeAlD
Nelarabine—DGUOK—cerebellum—amyotrophic lateral sclerosis	0.0105	0.0788	CbGeAlD
Nelarabine—Amnesia—Riluzole—amyotrophic lateral sclerosis	0.0101	0.0134	CcSEcCtD
Nelarabine—Osteoarthritis—Riluzole—amyotrophic lateral sclerosis	0.00944	0.0126	CcSEcCtD
Nelarabine—Ataxia—Riluzole—amyotrophic lateral sclerosis	0.00888	0.0118	CcSEcCtD
Nelarabine—DCK—embryo—amyotrophic lateral sclerosis	0.00888	0.0663	CbGeAlD
Nelarabine—Dehydration—Riluzole—amyotrophic lateral sclerosis	0.00878	0.0117	CcSEcCtD
Nelarabine—Hypokalaemia—Riluzole—amyotrophic lateral sclerosis	0.00859	0.0114	CcSEcCtD
Nelarabine—DGUOK—brain—amyotrophic lateral sclerosis	0.00857	0.064	CbGeAlD
Nelarabine—Aspartate aminotransferase increased—Riluzole—amyotrophic lateral sclerosis	0.0085	0.0113	CcSEcCtD
Nelarabine—Muscular weakness—Riluzole—amyotrophic lateral sclerosis	0.00833	0.0111	CcSEcCtD
Nelarabine—POLA1—E2F transcription factor network—UXT—amyotrophic lateral sclerosis	0.00824	0.091	CbGpPWpGaD
Nelarabine—Abdominal distension—Riluzole—amyotrophic lateral sclerosis	0.00822	0.0109	CcSEcCtD
Nelarabine—Neutropenia—Riluzole—amyotrophic lateral sclerosis	0.00763	0.0102	CcSEcCtD
Nelarabine—Pneumonia—Riluzole—amyotrophic lateral sclerosis	0.00732	0.00974	CcSEcCtD
Nelarabine—Infestation NOS—Riluzole—amyotrophic lateral sclerosis	0.00728	0.00969	CcSEcCtD
Nelarabine—Infestation—Riluzole—amyotrophic lateral sclerosis	0.00728	0.00969	CcSEcCtD
Nelarabine—Depression—Riluzole—amyotrophic lateral sclerosis	0.00726	0.00966	CcSEcCtD
Nelarabine—Neuropathy peripheral—Riluzole—amyotrophic lateral sclerosis	0.00713	0.00949	CcSEcCtD
Nelarabine—Stomatitis—Riluzole—amyotrophic lateral sclerosis	0.00709	0.00944	CcSEcCtD
Nelarabine—Hepatobiliary disease—Riluzole—amyotrophic lateral sclerosis	0.00688	0.00916	CcSEcCtD
Nelarabine—Epistaxis—Riluzole—amyotrophic lateral sclerosis	0.00686	0.00914	CcSEcCtD
Nelarabine—Sinusitis—Riluzole—amyotrophic lateral sclerosis	0.00683	0.00909	CcSEcCtD
Nelarabine—POLA1—cerebellum—amyotrophic lateral sclerosis	0.00651	0.0486	CbGeAlD
Nelarabine—Hypoaesthesia—Riluzole—amyotrophic lateral sclerosis	0.0065	0.00865	CcSEcCtD
Nelarabine—Urinary tract disorder—Riluzole—amyotrophic lateral sclerosis	0.00645	0.00859	CcSEcCtD
Nelarabine—Oedema peripheral—Riluzole—amyotrophic lateral sclerosis	0.00644	0.00857	CcSEcCtD
Nelarabine—Connective tissue disorder—Riluzole—amyotrophic lateral sclerosis	0.00642	0.00854	CcSEcCtD
Nelarabine—ADA—nervous system—amyotrophic lateral sclerosis	0.00641	0.0479	CbGeAlD
Nelarabine—Urethral disorder—Riluzole—amyotrophic lateral sclerosis	0.0064	0.00852	CcSEcCtD
Nelarabine—ADA—central nervous system—amyotrophic lateral sclerosis	0.00617	0.0461	CbGeAlD
Nelarabine—Eye disorder—Riluzole—amyotrophic lateral sclerosis	0.00611	0.00813	CcSEcCtD
Nelarabine—Cardiac disorder—Riluzole—amyotrophic lateral sclerosis	0.00606	0.00807	CcSEcCtD
Nelarabine—Angiopathy—Riluzole—amyotrophic lateral sclerosis	0.00593	0.00789	CcSEcCtD
Nelarabine—Mediastinal disorder—Riluzole—amyotrophic lateral sclerosis	0.00589	0.00784	CcSEcCtD
Nelarabine—Chills—Riluzole—amyotrophic lateral sclerosis	0.00586	0.0078	CcSEcCtD
Nelarabine—Mental disorder—Riluzole—amyotrophic lateral sclerosis	0.00572	0.00762	CcSEcCtD
Nelarabine—Malnutrition—Riluzole—amyotrophic lateral sclerosis	0.00569	0.00757	CcSEcCtD
Nelarabine—DCK—medulla oblongata—amyotrophic lateral sclerosis	0.00567	0.0424	CbGeAlD
Nelarabine—Dysgeusia—Riluzole—amyotrophic lateral sclerosis	0.00557	0.00741	CcSEcCtD
Nelarabine—Back pain—Riluzole—amyotrophic lateral sclerosis	0.0055	0.00732	CcSEcCtD
Nelarabine—ADA—Circadian rythm related genes—SETX—amyotrophic lateral sclerosis	0.00543	0.0599	CbGpPWpGaD
Nelarabine—Tremor—Riluzole—amyotrophic lateral sclerosis	0.00533	0.00709	CcSEcCtD
Nelarabine—POLA1—brain—amyotrophic lateral sclerosis	0.00528	0.0395	CbGeAlD
Nelarabine—Anaemia—Riluzole—amyotrophic lateral sclerosis	0.00526	0.007	CcSEcCtD
Nelarabine—Leukopenia—Riluzole—amyotrophic lateral sclerosis	0.00509	0.00678	CcSEcCtD
Nelarabine—DCK—spinal cord—amyotrophic lateral sclerosis	0.00506	0.0378	CbGeAlD
Nelarabine—Loss of consciousness—Riluzole—amyotrophic lateral sclerosis	0.005	0.00665	CcSEcCtD
Nelarabine—Cough—Riluzole—amyotrophic lateral sclerosis	0.00496	0.0066	CcSEcCtD
Nelarabine—Convulsion—Riluzole—amyotrophic lateral sclerosis	0.00493	0.00656	CcSEcCtD
Nelarabine—ADA—brain—amyotrophic lateral sclerosis	0.0049	0.0366	CbGeAlD
Nelarabine—Arthralgia—Riluzole—amyotrophic lateral sclerosis	0.00484	0.00644	CcSEcCtD
Nelarabine—Chest pain—Riluzole—amyotrophic lateral sclerosis	0.00484	0.00644	CcSEcCtD
Nelarabine—Myalgia—Riluzole—amyotrophic lateral sclerosis	0.00484	0.00644	CcSEcCtD
Nelarabine—Confusional state—Riluzole—amyotrophic lateral sclerosis	0.00468	0.00623	CcSEcCtD
Nelarabine—Oedema—Riluzole—amyotrophic lateral sclerosis	0.00464	0.00618	CcSEcCtD
Nelarabine—Infection—Riluzole—amyotrophic lateral sclerosis	0.00461	0.00614	CcSEcCtD
Nelarabine—Nervous system disorder—Riluzole—amyotrophic lateral sclerosis	0.00455	0.00606	CcSEcCtD
Nelarabine—Thrombocytopenia—Riluzole—amyotrophic lateral sclerosis	0.00454	0.00605	CcSEcCtD
Nelarabine—ADA—Nucleotide metabolism—GSR—amyotrophic lateral sclerosis	0.00444	0.0489	CbGpPWpGaD
Nelarabine—Anorexia—Riluzole—amyotrophic lateral sclerosis	0.00442	0.00589	CcSEcCtD
Nelarabine—ADA—Validated transcriptional targets of deltaNp63 isoforms—IGFBP3—amyotrophic lateral sclerosis	0.00434	0.0479	CbGpPWpGaD
Nelarabine—Hypotension—Riluzole—amyotrophic lateral sclerosis	0.00434	0.00577	CcSEcCtD
Nelarabine—DCK—nervous system—amyotrophic lateral sclerosis	0.00426	0.0318	CbGeAlD
Nelarabine—Musculoskeletal discomfort—Riluzole—amyotrophic lateral sclerosis	0.00423	0.00563	CcSEcCtD
Nelarabine—Insomnia—Riluzole—amyotrophic lateral sclerosis	0.0042	0.00559	CcSEcCtD
Nelarabine—Paraesthesia—Riluzole—amyotrophic lateral sclerosis	0.00417	0.00555	CcSEcCtD
Nelarabine—Dyspnoea—Riluzole—amyotrophic lateral sclerosis	0.00414	0.00551	CcSEcCtD
Nelarabine—Somnolence—Riluzole—amyotrophic lateral sclerosis	0.00413	0.00549	CcSEcCtD
Nelarabine—DCK—central nervous system—amyotrophic lateral sclerosis	0.0041	0.0307	CbGeAlD
Nelarabine—DCK—Nucleotide metabolism—GSR—amyotrophic lateral sclerosis	0.00409	0.0452	CbGpPWpGaD
Nelarabine—Decreased appetite—Riluzole—amyotrophic lateral sclerosis	0.00403	0.00537	CcSEcCtD
Nelarabine—DCK—cerebellum—amyotrophic lateral sclerosis	0.00401	0.03	CbGeAlD
Nelarabine—Gastrointestinal disorder—Riluzole—amyotrophic lateral sclerosis	0.00401	0.00533	CcSEcCtD
Nelarabine—Fatigue—Riluzole—amyotrophic lateral sclerosis	0.004	0.00533	CcSEcCtD
Nelarabine—Pain—Riluzole—amyotrophic lateral sclerosis	0.00397	0.00528	CcSEcCtD
Nelarabine—Constipation—Riluzole—amyotrophic lateral sclerosis	0.00397	0.00528	CcSEcCtD
Nelarabine—ADA—Validated transcriptional targets of TAp63 isoforms—IGFBP3—amyotrophic lateral sclerosis	0.00388	0.0428	CbGpPWpGaD
Nelarabine—Feeling abnormal—Riluzole—amyotrophic lateral sclerosis	0.00382	0.00509	CcSEcCtD
Nelarabine—Gastrointestinal pain—Riluzole—amyotrophic lateral sclerosis	0.0038	0.00505	CcSEcCtD
Nelarabine—Abdominal pain—Riluzole—amyotrophic lateral sclerosis	0.00367	0.00488	CcSEcCtD
Nelarabine—Body temperature increased—Riluzole—amyotrophic lateral sclerosis	0.00367	0.00488	CcSEcCtD
Nelarabine—Asthenia—Riluzole—amyotrophic lateral sclerosis	0.00333	0.00443	CcSEcCtD
Nelarabine—DCK—brain—amyotrophic lateral sclerosis	0.00326	0.0243	CbGeAlD
Nelarabine—Diarrhoea—Riluzole—amyotrophic lateral sclerosis	0.00318	0.00423	CcSEcCtD
Nelarabine—Dizziness—Riluzole—amyotrophic lateral sclerosis	0.00307	0.00408	CcSEcCtD
Nelarabine—Vomiting—Riluzole—amyotrophic lateral sclerosis	0.00295	0.00393	CcSEcCtD
Nelarabine—Headache—Riluzole—amyotrophic lateral sclerosis	0.00291	0.00387	CcSEcCtD
Nelarabine—Nausea—Riluzole—amyotrophic lateral sclerosis	0.00276	0.00367	CcSEcCtD
Nelarabine—DGUOK—Metabolism—TPK1—amyotrophic lateral sclerosis	0.0024	0.0265	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—VAPB—amyotrophic lateral sclerosis	0.0024	0.0265	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—VAPA—amyotrophic lateral sclerosis	0.0022	0.0242	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.00204	0.0225	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—FIG4—amyotrophic lateral sclerosis	0.00192	0.0212	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—CASP12—amyotrophic lateral sclerosis	0.00187	0.0206	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—DAO—amyotrophic lateral sclerosis	0.00174	0.0191	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—RARA—amyotrophic lateral sclerosis	0.00152	0.0168	CbGpPWpGaD
Nelarabine—ADA—Circadian rythm related genes—CST3—amyotrophic lateral sclerosis	0.00144	0.0159	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—PLB1—amyotrophic lateral sclerosis	0.00132	0.0145	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—GSR—amyotrophic lateral sclerosis	0.00121	0.0134	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—MAPT—amyotrophic lateral sclerosis	0.00105	0.0115	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—CST3—amyotrophic lateral sclerosis	0.00101	0.0112	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000997	0.011	CbGpPWpGaD
Nelarabine—ADA—C-MYB transcription factor network—PTGS2—amyotrophic lateral sclerosis	0.000956	0.0105	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—IGFBP3—amyotrophic lateral sclerosis	0.000955	0.0105	CbGpPWpGaD
Nelarabine—ADA—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000797	0.00879	CbGpPWpGaD
Nelarabine—ADA—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000797	0.00879	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—CASP9—amyotrophic lateral sclerosis	0.000738	0.00814	CbGpPWpGaD
Nelarabine—POLA1—Cell Cycle, Mitotic—TUBA4A—amyotrophic lateral sclerosis	0.000736	0.00812	CbGpPWpGaD
Nelarabine—POLA1—Cell Cycle, Mitotic—OPTN—amyotrophic lateral sclerosis	0.000736	0.00812	CbGpPWpGaD
Nelarabine—DCK—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000735	0.00811	CbGpPWpGaD
Nelarabine—DCK—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000735	0.00811	CbGpPWpGaD
Nelarabine—ADA—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000729	0.00804	CbGpPWpGaD
Nelarabine—ADA—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000678	0.00748	CbGpPWpGaD
Nelarabine—DCK—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000673	0.00742	CbGpPWpGaD
Nelarabine—POLA1—Cell Cycle—OPTN—amyotrophic lateral sclerosis	0.000658	0.00726	CbGpPWpGaD
Nelarabine—POLA1—Cell Cycle—TUBA4A—amyotrophic lateral sclerosis	0.000658	0.00726	CbGpPWpGaD
Nelarabine—ADA—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000637	0.00703	CbGpPWpGaD
Nelarabine—POLA1—Cell Cycle, Mitotic—DCTN1—amyotrophic lateral sclerosis	0.000626	0.0069	CbGpPWpGaD
Nelarabine—DCK—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000625	0.0069	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—BDNF—amyotrophic lateral sclerosis	0.000622	0.00686	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—PLA2G4A—amyotrophic lateral sclerosis	0.000594	0.00655	CbGpPWpGaD
Nelarabine—DCK—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000588	0.00649	CbGpPWpGaD
Nelarabine—ADA—Metabolism—DAO—amyotrophic lateral sclerosis	0.000576	0.00636	CbGpPWpGaD
Nelarabine—POLA1—Cell Cycle—DCTN1—amyotrophic lateral sclerosis	0.00056	0.00617	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—GSTP1—amyotrophic lateral sclerosis	0.000536	0.00591	CbGpPWpGaD
Nelarabine—DCK—Metabolism—DAO—amyotrophic lateral sclerosis	0.000532	0.00587	CbGpPWpGaD
Nelarabine—DCK—Retinoblastoma (RB) in Cancer—TP53—amyotrophic lateral sclerosis	0.000511	0.00563	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000492	0.00543	CbGpPWpGaD
Nelarabine—ADA—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000437	0.00482	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—APOE—amyotrophic lateral sclerosis	0.000405	0.00447	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—IGF1—amyotrophic lateral sclerosis	0.000404	0.00445	CbGpPWpGaD
Nelarabine—DCK—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000403	0.00445	CbGpPWpGaD
Nelarabine—ADA—Metabolism—GSR—amyotrophic lateral sclerosis	0.000403	0.00445	CbGpPWpGaD
Nelarabine—POLA1—Retinoblastoma (RB) in Cancer—TP53—amyotrophic lateral sclerosis	0.000374	0.00412	CbGpPWpGaD
Nelarabine—DCK—Metabolism—GSR—amyotrophic lateral sclerosis	0.000372	0.0041	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—PTGS2—amyotrophic lateral sclerosis	0.000335	0.00369	CbGpPWpGaD
Nelarabine—ADA—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000331	0.00365	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—CASP3—amyotrophic lateral sclerosis	0.000311	0.00343	CbGpPWpGaD
Nelarabine—DCK—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000305	0.00337	CbGpPWpGaD
Nelarabine—ADA—Circadian rythm related genes—TP53—amyotrophic lateral sclerosis	0.000283	0.00312	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—PTGS2—amyotrophic lateral sclerosis	0.000278	0.00306	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—VEGFA—amyotrophic lateral sclerosis	0.000264	0.00291	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—TP53—amyotrophic lateral sclerosis	0.000199	0.0022	CbGpPWpGaD
Nelarabine—ADA—Metabolism—GSTP1—amyotrophic lateral sclerosis	0.000178	0.00196	CbGpPWpGaD
Nelarabine—DCK—Metabolism—GSTP1—amyotrophic lateral sclerosis	0.000164	0.00181	CbGpPWpGaD
Nelarabine—ADA—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000163	0.0018	CbGpPWpGaD
Nelarabine—DCK—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000151	0.00166	CbGpPWpGaD
Nelarabine—ADA—Metabolism—APOE—amyotrophic lateral sclerosis	0.000134	0.00148	CbGpPWpGaD
Nelarabine—DCK—Metabolism—APOE—amyotrophic lateral sclerosis	0.000124	0.00137	CbGpPWpGaD
Nelarabine—ADA—Metabolism—PTGS2—amyotrophic lateral sclerosis	9.21e-05	0.00102	CbGpPWpGaD
Nelarabine—POLA1—Cell Cycle—TP53—amyotrophic lateral sclerosis	8.62e-05	0.000951	CbGpPWpGaD
Nelarabine—DCK—Metabolism—PTGS2—amyotrophic lateral sclerosis	8.5e-05	0.000938	CbGpPWpGaD
